PSTV Insider Trading Activity and SEC Form 4 Filings
PSTV insider trading summary
No open-market insider purchases or sales of Plus Therapeutics, Inc. (PSTV) have been reported on SEC Form 4 in the past 12 months.
Latest PSTV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 4, 2025 | Andrew John Hugh MacIntyre Sims | Chief Financial Officer | Buy | $10K (20,000 @ $0.51) |
| Aug 22, 2025 | Robert P Lenk | Insider | Buy | $54K (110,000 @ $0.49) |
| Sep 13, 2024 | Richard J Hawkins | Insider | Buy | $6K (4,000 @ $1.50) |
| Sep 12, 2024 | Richard J Hawkins | Insider | Buy | $9K (6,285 @ $1.35) |
| Sep 11, 2024 | Howard Clowes | Insider | Buy | $7K (5,000 @ $1.34) |
| Sep 11, 2024 | Greg Petersen | Insider | Buy | $17K (12,500 @ $1.35) |
| Sep 10, 2024 | Marc H Hedrick | Chief Executive Officer | Buy | $10K (8,000 @ $1.23) |
| Sep 10, 2024 | Andrew John Hugh MacIntyre Sims | Chief Financial Officer | Buy | $5K (4,098 @ $1.27) |
| May 8, 2024 | Marc H Hedrick | Chief Executive Officer | Buy | $25K (12,255 @ $2.04) |
| May 8, 2024 | Richard J Hawkins | Insider | Buy | $10K (4,902 @ $2.04) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.